Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    L Histidine Hydrochloride Monohydrate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2COSENTYX

    02 1DARZALEX

    03 1GAMIFANT

    04 1IMJUDO

    05 1ONTRUZANT

    06 1OPDUALAG

    07 1SYLVANT

    08 1VYEPTI

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    ASTRAZENECA AB

    Tremelimumab-actl

    Health 2.0 Conference
    Not Confirmed
    arrow

    02

    BRISTOL MYERS SQUIBB

    Nivolumab;Relatlimab-rmbw

    Health 2.0 Conference
    Not Confirmed
    arrow

    03

    JANSSEN BIOTECH

    Daratumumab

    Health 2.0 Conference
    Not Confirmed
    arrow

    04

    Lundbeck Seattle BioPharmaceuticals, Inc.

    Eptinezumab-jjmr

    Health 2.0 Conference
    Not Confirmed
    arrow

    05

    NOVARTIS PHARMS CORP

    Secukinumab

    Health 2.0 Conference
    Not Confirmed
    arrow

    06

    NOVARTIS PHARMS CORP

    Secukinumab

    Health 2.0 Conference
    Not Confirmed
    arrow

    07

    NOVIMMUNE S.A.

    Emapalumab-lzsg

    Health 2.0 Conference
    Not Confirmed
    arrow

    08

    RECORDATI RARE DISEASES, INC.

    Siltuximab

    Health 2.0 Conference
    Not Confirmed
    arrow

    09

    SAMSUNG BIOEPIS CO LTD

    Trastuzumab-dttb

    Health 2.0 Conference
    Not Confirmed
    arrow
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.